IDH1 and neoplasm: Kaplan–Meier analyses demonstrated that the patients with relatively higher miR-29a/b/c levels exhibited longer DFS (P < 0.0001) and OS (P < 0.0001; Fig. 1d), even within the cohort of patients with the same tumor grade (Fig. 1e and Supplementary Fig. 3a, b), identical IDH status (Fig. 1f, g), similar age, and KPS (Supplementary Fig. 4a–d).